June 4, 2018 Treatment with docetaxel without prednisone failed to improve biochemical disease-free survival (DFS) compared with surveillance in patients who had undergone radical prostatectomy with androgen deprivation therapy for intermediate – or high-risk prostate cancer, according to the results of the SPCG-13 study (Abstract 5000) presented during the Genitourinary (Prostate) Cancer Oral Abstract...
Pro zobrazení tohoto obsahu je třeba být přihlášen.